title: Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin.
abstract: Mice lacking Epas1, encoding the transcription factor Hypoxia-inducible Factor 2alpha (HIF-2alpha), exhibit an apparent mitochondrial disease state. Similarities between knock-outs of Epas1 and of Sod2, encoding the mitochondrial antioxidant enzyme manganese superoxide dismutase, led to the identification of Sod2 as a HIF-2alpha target gene. However, Sod2 levels in Epas1(-)(/)(-) liver are intermediate between that of Sod(+)(/)(-) and Sod2(-)(/)(-) mice, which have subtle or severe phenotypes, respectively. This suggests that additional HIF-2alpha target genes besides Sod2 contribute to the Epas1(-)(/)(-) mitochondrial disease state. To define the nature of the mitochondrial defect in Epas1(-)(/)(-) liver, we performed biophysical, biochemical, and molecular studies. In the setting of decreased Sod2 levels and increased oxidative stress, we found reduced respiration, sensitized mitochondrial permeability transition pore opening, intact electron transport chain activities, and impaired mitochondrial aconitase activity. Mitochondrial aconitase protein levels were preserved, whereas mRNA and protein levels for frataxin, the oxidative stress-regulated mitochondrial aconitase chaperone protein, were markedly reduced in Epas1(-)(/)(-) livers. The mouse Fxn promoter was preferentially activated by HIF-2alpha through a consensus HIF-responsive enhancer element. In summary, the studies reveal that Fxn, like Sod2, is a nuclear-encoded, mitochondrial-localized HIF-2alpha target gene required for optimal mitochondrial homeostasis. These findings expand upon the previously defined role of HIF-2alpha in the cellular response to oxidative stress and identify a novel link of HIF-2alpha with mitochondrial homeostasis.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA.
authors.forename: Yavuz
authors.initials: Y
authors.lastname: Oktay
authors.forename: Elhadji
authors.initials: E
authors.lastname: Dioum
authors.forename: Satoshi
authors.initials: S
authors.lastname: Matsuzaki
authors.forename: Kan
authors.initials: K
authors.lastname: Ding
authors.forename: Liang-Jun
authors.initials: LJ
authors.lastname: Yan
authors.forename: Ronald G
authors.initials: RG
authors.lastname: Haller
authors.forename: Luke I
authors.initials: LI
authors.lastname: Szweda
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Garcia
mesh_terms: D000154:Aconitate Hydratase / Q000378:metabolism*; D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D051792:Basic Helix-Loop-Helix Proteins / Q000502:physiology*; D005786:Gene Expression Regulation; D033862:Iron-Binding Proteins / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D008928:Mitochondria / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism; D009097:Multienzyme Complexes / Q000378:metabolism; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D010766:Phosphorylation; D000096923:Frataxin; D000099162:Endothelial PAS Domain-Containing Protein 1
chemical_list: D000154:Aconitate Hydratase; D000975:Antioxidants; D051792:Basic Helix-Loop-Helix Proteins; D033862:Iron-Binding Proteins; D009097:Multienzyme Complexes; D009247:NADH, NADPH Oxidoreductases; D000096923:Frataxin; D000099162:Endothelial PAS Domain-Containing Protein 1; C023107:NADH oxidase